Identifying high-risk smouldering myeloma to improve patient outcomes
Dr Melissa Cantley hopes that those who have this pre-canerous condition will be able to be tested to understand their risk of developing myeloma.
- Myeloma
- Research
Category: Research
Using precision medicine to reduce long-term ALL treatment effects
Professor Deb White hopes to reduce the toxic impact of ALL therapy.
- Acute lymphoblastic leukaemia
Expert Series: Dr Rishi Kotecha on paediatric ALL
Dr Rishi Kotecha talks about the revolutionary treatments which are improving outcomes for babies and children with high-risk leukaemia.
- Acute lymphoblastic leukaemia
- Interviews with experts
- Research
Expert Series: Dr Cecily Forsyth on how to live your best life with MPN
Dr Forsyth is passionate about what MPN patients can do to improve their health.
- Interviews with experts
- Lifestyle and living well
- Myeloproliferative neoplasms
AL amyloidosis trials due to open this year offer “new hope”
Two clinical trials will open later this year for newly diagnosed patients with AL amyloidosis with moderate to severe cardiac disease.
- Amyloidosis
- Clinical trials
- Research
- Treatments and side-effects
Expert Series: Dr Simon Gibbs on all things amyloidosis
Dr Gibbs discusses everything from the incidence, diagnosis and treatment of amyloidosis, to supportive care, quality of life, and how he came to specialise in this field.
- Amyloidosis
- Interviews with experts
- Research
Expert Series: Dr Susan Branford on molecular monitoring and drug resistance in CML
Professor Susan Branford’s work has underpinned many Australian and internationally significant developments in CML over the last 20 years.
- Chronic myeloid leukaemia
- Interviews with experts
The importance of molecular response in CML
Dr Susan Branford's research involved assessing people with CML to determine if monitoring the level of disease during therapy using a molecular marker could predict treatment outcome.
- Chronic myeloid leukaemia
- Research
Latest ALLG clinical trials recruiting for AML
Four clinical trials run by the Australasian Leukaemia & Lymphoma Group* (ALLG) are currently open to a range of people with acute myeloid leukaemia (AML) across Australia.
- Acute myeloid leukaemia
- Clinical trials
- Research
New 3D models could revolutionise drug testing
Dr Laura bray hopes her work will provide answers to the many unknowns faced by people with AML.
- Acute myeloid leukaemia
